The role of geroscience in understanding Alzheimer’s Disease

For more than 30 years, researchers have identified and quantified genetic and lifestyle factors for Alzheimer’s Disease (AD) and other dementias. Despite extensive research, the fundamental mechanisms behind these neurodegenerative diseases are still not fully understood, and effective management of AD is taking longer than expected.

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology – Biotech Investments

EQS-News: BRAIN Biotech AG / Key word(s): Contract BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology 31.10.2024

November 1, 2024

Bill Would Allow AI to Prescribe Drugs

Artificial intelligence (AI) could be used to prescribe medications to patients — if a new bill makes its way through Congress. The proposed legislation, sponsored

February 11, 2025

Pet ownership may not be beneficial for mental health of people with serious mental illness

Living with and having a close bond with a companion animal does not necessarily lead to significant mental health improvements in people with a serious

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.